Electra Therapeutics, Inc. (ETRA)Healthcare | Biotechnology | South San Francisco, United States | NasdaqGS
9.04 USD
-0.10
(-1.094%) ⇩
(Oct. 9, 2026, 4 p.m.
EDT)
After hours: 9.04 |
Hot Take ↕ | Oct. 10, 2026, 5:52 a.m. EDT
The immediate outlook is severely bearish due to a crushing technical setup where the price trades significantly below both the 50-day and 200-day averages, indicating a deep and persistent downtrend rather than a temporary dip. This weakness is compounded by a lack of analyst coverage and a statistical forecasting model that offers no predictive power, leaving the stock exposed to pure noise. From a long-term perspective, the business fundamentals are catastrophic: the company reports negative earnings, generates substantial negative operating cash flow, and possesses a negative book value, signaling that the market has priced in a severe impairment of the underlying enterprise value. Furthermore, the price history reveals a multi-year structural decline with consecutive negative annual returns, confirming that the market has repeatedly rejected the company's performance over time. Finally, there is no dividend to provide any income cushion, making this a high-risk speculative vehicle with no safety margin. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.162 |
| Market Cap | 567,413,248 |
| Website | https://electra-therapeutics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.31773585 |
| Address1 | 230 E Grand Avenue |
| Address2 | Suite S-100 |
| All Time High | 15.5 |
| All Time Low | 8.63 |
| Ask | 9.19 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 633,480 |
| Average Daily Volume3 Month | 904,437 |
| Average Volume | 904,437 |
| Average Volume10Days | 633,480 |
| Bid | 8.82 |
| Bid Size | 1 |
| Book Value | -4,987.614 |
| City | South San Francisco |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 9.04 |
| Current Ratio | 7.365 |
| Custom Price Alert Confidence | HIGH |
| Day High | 9.295 |
| Day Low | 8.675 |
| Debt To Equity | 2.162 |
| Display Name | Electra Therapeutics |
| Dividend Yield | 0.0 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 775,107,648 |
| Eps Trailing Twelve Months | -2.65 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 11.16875 |
| Fifty Day Average Change | -2.1287498 |
| Fifty Day Average Change Percent | -0.19059876 |
| Fifty Two Week Change Percent | -31.773584 |
| Fifty Two Week High | 15.5 |
| Fifty Two Week High Change | -6.46 |
| Fifty Two Week High Change Percent | -0.41677418 |
| Fifty Two Week Low | 8.63 |
| Fifty Two Week Low Change | 0.40999985 |
| Fifty Two Week Low Change Percent | 0.047508672 |
| Fifty Two Week Range | 8.63 - 15.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,789,738,200,000 |
| Float Shares | 29,116,120 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 46 |
| Fullday Change | -0.10000038 |
| Fullday Change Percent | -1.0940961 |
| Fullday Price | 9.04 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.013710001 |
| Held Percent Institutions | 0.25728 |
| Implied Shares Outstanding | 62,766,955 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-09-18 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California. |
| Long Name | Electra Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 567,413,248 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1771786528 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -95,201,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 790,235,963 |
| Open | 9.13 |
| Operating Cashflow | -74,675,000 |
| Operating Margins | 0.0 |
| Phone | (888) 743-2290 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 9.04 |
| Post Market Time | 1,791,576,023 |
| Previous Close | 9.14 |
| Price Hint | 2 |
| Price To Book | -0.0018124899 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.191 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.10000038 |
| Regular Market Change Percent | -1.0940961 |
| Regular Market Day High | 9.295 |
| Regular Market Day Low | 8.675 |
| Regular Market Day Range | 8.675 - 9.295 |
| Regular Market Open | 9.13 |
| Regular Market Previous Close | 9.14 |
| Regular Market Price | 9.04 |
| Regular Market Time | 1,791,576,001 |
| Regular Market Volume | 778,453 |
| Sand P52 Week Change | 0.17383456 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 62,766,955 |
| Short Name | Electra Therapeutics, Inc. |
| Source Interval | 15 |
| State | CA |
| Symbol | ETRA |
| Total Cash | 97,725,000 |
| Total Cash Per Share | 1.599 |
| Total Debt | 1,983,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.65 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.16875 |
| Two Hundred Day Average Change | -2.1287498 |
| Two Hundred Day Average Change Percent | -0.19059876 |
| Type Disp | Equity |
| Volume | 778,453 |
| Website | https://electra-therapeutics.com |
| Zip | 94,080 |